HomeComparePKI vs FITB

PKI vs FITB: Dividend Comparison 2026

PKI yields 0.24% · FITB yields 3.45%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FITB wins by $170.4K in total portfolio value
10 years
PKI
PKI
● Live price
0.24%
Share price
$115.24
Annual div
$0.28
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19.7K
Annual income
$0.02
Full PKI calculator →
FITB
FITB
● Live price
3.45%
Share price
$44.68
Annual div
$1.54
5Y div CAGR
45.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$190.1K
Annual income
$82,140.41
Full FITB calculator →

Portfolio growth — PKI vs FITB

📍 FITB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPKIFITB
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PKI + FITB cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PKI pays
FITB pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PKI
Annual income on $10K today (after 15% tax)
$20.65/yr
After 10yr DRIP, annual income (after tax)
$0.02/yr
FITB
Annual income on $10K today (after 15% tax)
$292.97/yr
After 10yr DRIP, annual income (after tax)
$69,819.35/yr
At 15% tax rate, FITB beats the other by $69,819.33/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PKI + FITB for your $10,000?

PKI: 50%FITB: 50%
100% FITB50/50100% PKI
Portfolio after 10yr
$104.9K
Annual income
$41,070.21/yr
Blended yield
39.14%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on FITB right now

PKI
Analyst Ratings
13
Buy
18
Hold
Consensus: Hold
Price Target
$166.57
+44.5% upside vs current
Range: $145.00 — $202.00
Altman Z
2.9
Piotroski
7/9
FITB
Analyst Ratings
1
Strong
26
Buy
22
Hold
2
Sell
Consensus: Buy
Price Target
$56.90
+27.4% upside vs current
Range: $50.00 — $61.00
Altman Z
0.2
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PKI buys
0
FITB buys
0
No recent congressional trades found for PKI or FITB in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPKIFITB
Forward yield0.24%3.45%
Annual dividend / share$0.28$1.54
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%45.8%
Portfolio after 10y$19.7K$190.1K
Annual income after 10y$0.02$82,140.41
Total dividends collected$24.00$157.8K
Payment frequencyquarterlyquarterly
SectorStockFinancials
Analyst consensusHoldBuy
Analyst price target$166.57$56.90

Year-by-year: PKI vs FITB ($10,000, DRIP)

YearPKI PortfolioPKI Income/yrFITB PortfolioFITB Income/yrGap
1← crossover$10,712$12.15$11,203$502.53$491.00FITB
2$11,468$6.08$12,754$767.11$1.3KFITB
3$12,274$3.04$14,837$1,190.02$2.6KFITB
4$13,135$1.52$17,762$1,886.34$4.6KFITB
5$14,055$0.76$22,082$3,077.09$8.0KFITB
6$15,039$0.38$28,840$5,212.79$13.8KFITB
7$16,092$0.19$40,136$9,277.03$24.0KFITB
8$17,218$0.10$60,538$17,592.13$43.3KFITB
9$18,424$0.05$100,932$36,156.20$82.5KFITB
10$19,713$0.02$190,137$82,140.41$170.4KFITB

PKI vs FITB: Complete Analysis 2026

PKIStock

PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for the environmental, food, and industrial markets that enable its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

Full PKI Calculator →

FITBFinancials

Fifth Third Bancorp operates as a diversified financial services company in the United States. The company's Commercial Banking segment offers credit intermediation, cash management, and financial services; lending and depository products; and cash management, foreign exchange and international trade finance, derivatives and capital markets services, asset-based lending, real estate finance, public finance, commercial leasing, and syndicated finance for business, government, and professional customers. Its Branch Banking segment provides a range of deposit and loan products to individuals and small businesses. This segment offers checking and savings accounts, home equity loans and lines of credit, credit cards, and loans for automobiles and personal financing needs, as well as cash management services for small businesses. The company's Consumer Lending segment engages in direct lending activities that include origination, retention, and servicing of residential mortgage and home equity loans or lines of credit; and indirect lending activities, including loans to consumers through correspondent lenders and automobile dealers. Fifth Third Bancorp's Wealth & Asset Management segment provides various investment alternatives for individuals, companies, and not-for-profit organizations. It offers retail brokerage services to individual clients; and broker dealer services to the institutional marketplace. This segment also provides wealth planning, investment management, banking, insurance, and trust and estate services; and advisory services for institutional clients comprising middle market businesses, non-profits, states, and municipalities. As of December 31, 2021, the company operated 1,117 full-service banking centers and 2,322 ATMs in Ohio, Kentucky, Indiana, Michigan, Illinois, Florida, Tennessee, West Virginia, Georgia, North Carolina, and South Carolina. Fifth Third Bancorp was founded in 1858 and is headquartered in Cincinnati, Ohio.

Full FITB Calculator →
📬

Get this PKI vs FITB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PKI vs SCHDPKI vs JEPIPKI vs OPKI vs KOPKI vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.